$151 Million is the total value of HealthInvest Partners AB's 17 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $11,699,000 | – | 465,000 | +100.0% | 7.75% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $10,428,000 | – | 600,000 | +100.0% | 6.91% | – |
| VTRS | New | VIATRIS INC | $9,839,000 | – | 525,000 | +100.0% | 6.52% | – |
| CI | New | CIGNA CORP NEW | $9,784,000 | – | 47,000 | +100.0% | 6.48% | – |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $9,614,000 | – | 480,000 | +100.0% | 6.37% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $9,511,000 | – | 835,000 | +100.0% | 6.30% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $9,350,000 | – | 68,000 | +100.0% | 6.19% | – |
| ABBV | New | ABBVIE INC | $9,322,000 | – | 87,000 | +100.0% | 6.17% | – |
| MCK | New | MCKESSON CORP | $9,218,000 | – | 53,000 | +100.0% | 6.10% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $9,092,000 | – | 93,000 | +100.0% | 6.02% | – |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $9,056,000 | – | 146,000 | +100.0% | 6.00% | – |
| CAH | New | CARDINAL HEALTH INC | $9,052,000 | – | 169,000 | +100.0% | 6.00% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $8,830,000 | – | 915,000 | +100.0% | 5.85% | – |
| ARAY | New | ACCURAY INC | $6,881,000 | – | 1,650,000 | +100.0% | 4.56% | – |
| ATRS | New | ANTARES PHARMA INC | $6,863,000 | – | 1,720,000 | +100.0% | 4.54% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $6,615,000 | – | 1,575,000 | +100.0% | 4.38% | – |
| CPRX | New | CATALYST PHARMACEUTICALS INC | $5,845,000 | – | 1,750,000 | +100.0% | 3.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.